Symbol
| BCAR1
| contributors: mct - updated : 30-11-2017
|
HGNC name
| breast cancer anti-estrogen resistance 1
|
HGNC id
| 971
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --over
|  
|
overexpression confers anti-estrogen resistance on breast cancer cells | tumoral
|  
|  
| --over
|  
|
linked to poor prognosis in breast cancer patients | tumoral
|  
|  
| --over
|  
|
associated with poor prognosis of patients with lung cancer | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
cancer | reproductive | breast | |
potential use as a novel therapeutic target in ERBB2 positive human breast cancers | miscelleaneous | hypertension | | |
CAS-associated processes may be new biological targets for the development of new treatment of cardiovascular diseases such as hypertension |
| | | |